Patents by Inventor Gary D. Madding

Gary D. Madding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7388098
    Abstract: Provided is a dynamic resolution method of enriching a desired isomer of an alpha-substituted carboxylic acid relative to an undesired isomer, the method comprising: (a) in a solvent, contacting the alpha-substituted carboxylic acid, wherein the alpha substitution is with a leaving group and wherein the alpha carbon is chiral, with a homochiral amine to form a salt that is partially insoluble under selected reaction conditions, wherein the homochiral amine is selected so that the solubility of the amine salt of the undesired alpha-substituted carboxylic acid is greater than that of the amine salt of the desired alpha-substituted carboxylic acid under the selected reaction conditions; (b) reacting under the selected reaction conditions the salt with a nucleophile, wherein the reacting is effective in producing a net increase in the less soluble amine salt of the alpha-substituted carboxylic acid, and wherein the selected conditions are selected to (i) promote nucleophilic substitution of the nucleophile and th
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: June 17, 2008
    Assignee: Bristol-Myers Squibb Company
    Inventors: John J. Venit, Gary D. Madding, Victor W. Rosso, Francis J. Okuniewicz, Robert P. Discordia, Susanne Kiau, Atul S. Kotnis, Michael E. Randazzo, D. David Hennings, Jingyang Zhu, Jason G. Chen
  • Publication number: 20020111512
    Abstract: Provided is a dynamic resolution method of enriching a desired isomer of an alpha-substituted carboxylic acid relative to an undesired isomer, the method comprising: (a) in a solvent, contacting the alpha-substituted carboxylic acid, wherein the alpha substitution is with a leaving group and wherein the alpha carbon is chiral, with a homochiral amine to form a salt that is partially insoluble under selected reaction conditions, wherein the homochiral amine is selected so that the solubility of the amine salt of the undesired alpha-substituted carboxylic acid is greater than that of the amine salt of the desired alpha-substituted carboxylic acid under the selected reaction conditions; (b) reacting under the selected reaction conditions the salt with a nucleophile, wherein the reacting is effective in producing a net increase in the less soluble amine salt of the alpha-substituted carboxylic acid, and wherein the selected conditions are selected to (i) promote nucleophilic substitution of the nucleophile and th
    Type: Application
    Filed: September 24, 2001
    Publication date: August 15, 2002
    Inventors: John J. Venit, Gary D. Madding, Victor W. Rosso, Francis J. Okuniewicz, Robert P. Discordia, Susanne Kiau, Atul S. Kotnis, Michael E. Randazzo, D. David Hennings, Jingyang Zhu, Jason G. Chen
  • Patent number: 5521313
    Abstract: An improved process for preparation of certain useful azapirones, e.g. buspirone, gepirone, tandospirone, etc., comprises the reaction of a novel spiroquaternary piperazinium hydroxide with an appropriate imide to form imidate salts which are then converted to the azapirone by heating. This process is suitable for large scale adaptation and has advantages in greater safety and efficiency.
    Type: Grant
    Filed: May 5, 1994
    Date of Patent: May 28, 1996
    Assignee: Bristol-Myers Squibb Company
    Inventor: Gary D. Madding
  • Patent number: 4963678
    Abstract: An improved process, suitable for adaption to large-scale manufacture for synthesis of the cerebral function enhancing agent BMY 21502.
    Type: Grant
    Filed: October 27, 1989
    Date of Patent: October 16, 1990
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Gary D. Madding, Joseph L. Minielli, Ronald J. Mattson
  • Patent number: 4701528
    Abstract: There are disclosed compounds of Formulas I and II: ##STR1## wherein R.sup.1 and R.sup.2 may be hydrogen, lower alkyl having from 1 to 8 carbon atoms, lower alkenyl having from 3 to 6 carbon atoms, lower alkoxy having from 1 to 6 carbon atoms, hydroxy, nitro, amino, halo including chlorine, bromine, iodine, and fluorine, phenyl, alkanoyl having from 2 to 6 carbon atoms or they are bonded to one another to form a cycloalkene ring fused to the thiophene ring and having a total of from 5 to 7 annular ring carbon atoms, and R.sup.3 is an aliphatic or an aromatic group such as lower alkyl, e.g., methyl or ethyl. Such compounds are useful as intermediates in the production of tiprinast and related compounds.There is also disclosed a process for the regioselective synthesis of a compound of Formula I wherein R.sup.1 is CH.sub.3 and R.sup.2 is (CH.sub.3).sub.2 CHCH.sub.2 which comprises reacting a mixture of compounds of the following formulas: ##STR2## and ##STR3## with trichloroacetonitrile under acidic conditions.
    Type: Grant
    Filed: December 23, 1985
    Date of Patent: October 20, 1987
    Assignee: Bristol-Myers Company
    Inventors: Michael D. Thompson, Gary D. Madding
  • Patent number: 4596884
    Abstract: An improved process for the preparation of 5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazolone, a useful intermediate in the synthesis of antidepressant 1,2,4-triazolones typified by 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-4-(2-phenoxethyl)-2 H-1,2,4-triazol-3(4H)-one, also known as nefazodone. The improved process is shorter and higher in yield than the former process, and the starting materials are cheap and readily available.
    Type: Grant
    Filed: June 3, 1985
    Date of Patent: June 24, 1986
    Assignee: Bristol-Myers Company
    Inventor: Gary D. Madding
  • Patent number: 4454324
    Abstract: An improved process for the preparation of 4-methoxy-2'-{2-(1-methyl-2-piperidyl)ethyl}benzanilide has been developed. The process comprises essentially three steps starting with methyl anthranilate and 2-picoline and features a novel low-pressure hydrogenation sequence.
    Type: Grant
    Filed: April 1, 1983
    Date of Patent: June 12, 1984
    Assignee: Mead Johnson & Company
    Inventor: Gary D. Madding
  • Patent number: 4394507
    Abstract: An improved process for the preparation of 4-methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide has been developed. The process comprises essentially three steps starting with methyl anthranilate and 2-picoline and features a novel low-pressure hydrogenation sequence.
    Type: Grant
    Filed: December 14, 1981
    Date of Patent: July 19, 1983
    Assignee: Mead Johnson & Company
    Inventor: Gary D. Madding
  • Patent number: 3941854
    Abstract: Styrene and benzene are simultaneously produced by heating a mixture of toluene and ethylbenzene in a mole ratio of at least 1:1 to a temperature from about 400.degree. to 900.degree.C at moderate pressures for a period of time up to about 15 seconds, cooling the reaction mixture quickly and recovering the styrene and benzene therefrom. Yields of both products can be improved by the addition of modifying agents such as benzenethiol or by conducting the reaction in the presence of a chromium-containing catalyst supported on an inorganic material which can be promoted by a compound of calcium, magnesium, copper or zinc.
    Type: Grant
    Filed: April 25, 1974
    Date of Patent: March 2, 1976
    Assignee: Monsanto Company
    Inventors: Raymond A. Franz, Gary D. Madding, Tao P. Li